MedMira (Germany) Market Value
| 47M Stock | EUR 0.05 0 6.52% |
| Symbol | MedMira |
MedMira 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to MedMira's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of MedMira.
| 11/01/2024 |
| 12/01/2024 |
If you would invest 0.00 in MedMira on November 1, 2024 and sell it all today you would earn a total of 0.00 from holding MedMira or generate 0.0% return on investment in MedMira over 30 days. MedMira is related to or competes with Marie Brizard, Apollo Investment, NIPPON STEEL, Genco Shipping, Treasury Wine, United States, and EAT WELL. MedMira Inc., a biotechnology company, researches, develops, manufactures, and commercializes rapid diagnostics and tech... More
MedMira Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure MedMira's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess MedMira upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 10.03 | |||
| Information Ratio | 0.032 | |||
| Maximum Drawdown | 58.16 | |||
| Value At Risk | (10.78) | |||
| Potential Upside | 12.09 |
MedMira Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for MedMira's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as MedMira's standard deviation. In reality, there are many statistical measures that can use MedMira historical prices to predict the future MedMira's volatility.| Risk Adjusted Performance | 0.0445 | |||
| Jensen Alpha | 0.3199 | |||
| Total Risk Alpha | (1.18) | |||
| Sortino Ratio | 0.0308 | |||
| Treynor Ratio | 0.4786 |
MedMira Backtested Returns
MedMira appears to be out of control, given 3 months investment horizon. MedMira has Sharpe Ratio of 0.0366, which conveys that the firm had a 0.0366% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for MedMira, which you can use to evaluate the volatility of the firm. Please exercise MedMira's Mean Deviation of 5.23, downside deviation of 10.03, and Risk Adjusted Performance of 0.0445 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, MedMira holds a performance score of 2. The company secures a Beta (Market Risk) of 0.91, which conveys possible diversification benefits within a given portfolio. MedMira returns are very sensitive to returns on the market. As the market goes up or down, MedMira is expected to follow. Please check MedMira's market risk adjusted performance, semi deviation, coefficient of variation, as well as the relationship between the mean deviation and downside deviation , to make a quick decision on whether MedMira's current price movements will revert.
Auto-correlation | -0.35 |
Poor reverse predictability
MedMira has poor reverse predictability. Overlapping area represents the amount of predictability between MedMira time series from 1st of November 2024 to 16th of November 2024 and 16th of November 2024 to 1st of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of MedMira price movement. The serial correlation of -0.35 indicates that nearly 35.0% of current MedMira price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.35 | |
| Spearman Rank Test | -0.35 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
MedMira lagged returns against current returns
Autocorrelation, which is MedMira stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting MedMira's stock expected returns. We can calculate the autocorrelation of MedMira returns to help us make a trade decision. For example, suppose you find that MedMira has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
MedMira regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If MedMira stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if MedMira stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in MedMira stock over time.
Current vs Lagged Prices |
| Timeline |
MedMira Lagged Returns
When evaluating MedMira's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of MedMira stock have on its future price. MedMira autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, MedMira autocorrelation shows the relationship between MedMira stock current value and its past values and can show if there is a momentum factor associated with investing in MedMira.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in MedMira Stock
MedMira financial ratios help investors to determine whether MedMira Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in MedMira with respect to the benefits of owning MedMira security.